Management of Hemodynamically and Clinically Stable Patent Ductus Arteriosus

Initial Diagnostic Confirmation

The American College of Cardiology recommends performing echocardiography with color Doppler in the parasternal short-axis view to visualize the PDA and assess shunt direction 3, 4
Measuring transpulmonary gradient with continuous-wave Doppler is used to estimate pulmonary artery pressure in patients with PDA 4, 2
Assessing for left atrial and left ventricular enlargement is necessary to confirm hemodynamic stability, as the absence of chamber enlargement confirms stability 1, 5
Checking oxygen saturation in both feet and both hands is recommended to detect any differential cyanosis from right-to-left shunting in patients with PDA 1, 5

A small/audible PDA is characterized by a continuous murmur present, normal heart size, and no left heart volume overload 5
A silent/trivial PDA is defined as an inaudible murmur with hemodynamically insignificant shunting 6, 5

For hemodynamically stable PDAs without left heart enlargement, the American Heart Association recommends observation as the initial approach rather than immediate closure 2
Routine echocardiographic surveillance every 3-5 years is recommended to monitor for development of hemodynamic significance in patients with stable PDA 2

Monitoring for clinical signs, including development of continuous murmur, bounding pulses, wide pulse pressure, or symptoms of heart failure, is necessary in patients with stable PDA 3, 4
Reassessing if symptoms develop, such as shortness of breath, easy fatigability, or signs of pulmonary overcirculation, is crucial in patients with PDA 3

Closure should be pursued if left atrial or left ventricular enlargement attributable to the PDA develops during surveillance 1, 5, 2
Pulmonary hypertension with pulmonary artery pressure <2/3 systemic pressure and net left-to-right shunt is an indication for closure in patients with PDA 1
Prior history of endarteritis is a recommendation for closure in patients with PDA 1, 2
Net left-to-right shunt with Qp:Qs >1.5 is an indication for closure in patients with PDA 1

Transcatheter device closure is the first-line intervention for PDA closure, rather than surgical ligation, due to its superior safety profile and efficacy 1, 2
Surgical closure is reserved for PDAs too large for device closure, distorted ductal anatomy precluding device placement, calcified PDAs in adults, or when concomitant cardiac surgery is required 1, 2

The American Heart Association notes that endocarditis in silent ductus has been found only in single case reports, and there are few data supporting benefits of closure given the small size and lack of significant flow turbulence 6, 7
Closure may be reasonable even for small asymptomatic PDAs with continuous murmur by catheter device, according to the American College of Cardiology 6, 8, 2

Do not assume stability based on clinical exam alone - always confirm with echocardiography, as serious complications like pulmonary vascular disease can develop in patients with PDA 3, 4
Do not miss differential cyanosis - always check oxygen saturation in all four extremities to detect right-to-left shunting at the ductal level in patients with PDA 1, 5

Endocarditis prophylaxis is NOT routinely indicated for unrepaired PDA in hemodynamically stable patients, according to the American Heart Association 3
Prophylaxis is only indicated for unrepaired cyanotic CHD, first 6 months after device closure with prosthetic materials, or repaired CHD with residual defects at or adjacent to prosthetic material that inhibit endothelialization 3